Drug Shortage Report for DIPYRIDAMOLE INJECTION, USP
| Report ID | 193649 |
| Drug Identification Number | 02244475 |
| Brand name | DIPYRIDAMOLE INJECTION, USP |
| Common or Proper name | DIPYRIDAMOLE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | DIPYRIDAMOLE |
| Strength(s) | 5MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-07-01 |
| Actual start date | 2023-08-23 |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-28 |
| Company comments | Please be advised that this product is on 100% allocation. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-06-02 | French | Compare |
| v1 | 2023-06-02 | English | Compare |